Meningococcal vaccine study now enrolling
This study will help determine how safe the investigational vaccine is and whether it may act as a booster in people who have already received a vaccine against 4 of the most common types of meningococcal germs that cause meningitis. This could mean fewer injections in the future.
- are 15-25 years of age
- are healthy
- received 1 dose of a meningitis vaccine (MenACWY) 4–6 years ago.
- Compensation for time and travel
- Study vaccine at no cost